AAAAAA
Results:
1-7
|
Results: 7
Authors:
Liu, MC
Luo, MZ
Mozdziesz, DE
Lin, TS
Dutschman, GE
Gullen, EA
Cheng, YC
Sartorelli, AC
Citation: Mc. Liu et al., Synthesis and biological evaluation of L- and D-configurations of 2 ',3 '-dideoxy-4 '-C-methyl-3 '-oxacytidine analogues, BIOORG MED, 11(17), 2001, pp. 2301-2304
Authors:
Liu, MC
Luo, MZ
Mozdziesz, DE
Lin, TS
Dutschman, GE
Gullen, EA
Cheng, YC
Sartorelli, AC
Citation: Mc. Liu et al., Synthesis and biological evaluation of 1,3-oxathiolane 5-azapyrimidine, 6-azapyrimidine, and fluorosubstituted 3-deazapyrimidine nucleosides, NUCLEOS NUC, 19(3), 2000, pp. 603-618
Authors:
Luo, MZ
Liu, MC
Mozdziesz, DE
Lin, TS
Dutschman, GE
Gullen, EA
Cheng, YC
Sartorelli, AC
Citation: Mz. Luo et al., Synthesis and biological evaluation of L- and D-configuration 1,3-dioxolane 5-azacytosine and 6-azathymine nucleosides, BIOORG MED, 10(18), 2000, pp. 2145-2148
Authors:
Kira, T
Grill, SP
Dutschman, GE
Lin, JS
Qu, FC
Choi, YS
Chu, CK
Cheng, YC
Citation: T. Kira et al., Anti-Epstein-Barr virus (EBV) activity of beta-L-5-iododioxolane uracil isdependent on EBV thymidine kinase, ANTIM AG CH, 44(12), 2000, pp. 3278-3284
Authors:
Li, L
Dutschman, GE
Gullen, EA
Tsujii, E
Grill, SP
Choi, Y
Chu, CK
Cheng, YC
Citation: L. Li et al., Metabolism and mode of inhibition of varicella-zoster virus by 1-beta-5-bromovinyl-(2-hydroxymethyl)-(1,3-dioxolanyl)uracil is dependent on viral thymidine kinase, MOLEC PHARM, 58(5), 2000, pp. 1109-1114
Authors:
Liu, MC
Luo, MZ
Mozdziesz, DE
Lin, TS
Dutschman, GE
Cheng, YC
Sartorelli, AC
Citation: Mc. Liu et al., Synthesis of 2 '-methylene-substituted 5-azapyrimidine, 6-azapyrimidine, and 3-deazaguanine nucleoside analogues as potential antitumor/antiviral agents, NUCLEOS NUC, 18(1), 1999, pp. 55-72
Authors:
Chen, SH
Lin, S
King, I
Spinka, T
Dutschman, GE
Gullen, EA
Cheng, YC
Doyle, TW
Citation: Sh. Chen et al., Synthesis and comparative evaluation of two antiviral agents: beta-L-Fd(4)C and beta-D-Fd(4)C, BIOORG MED, 8(22), 1998, pp. 3245-3250
Risultati:
1-7
|